Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · IEX Real-Time Price · USD

394.28

+0.80 (0.20%)

At close: Apr 19, 2024, 4:00 PM

394.00

-0.28 (-0.07%)

After-hours: Apr 19, 2024, 7:42 PM EDT

Vertex Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Cash & Equivalents	10,369	10,504	6,795	5,988	3,109	2,650	1,665	1,232	815.76	633.85	Upgrade
Short-Term Investments	849.2	274.5	729.9	670.7	698.97	518.11	423.25	250.61	327.69	761.85	Upgrade
Cash & Cash Equivalents	11,218	10,779	7,525	6,659	3,808	3,168	2,089	1,482	1,143	1,396	Upgrade
Cash Growth	4.08%	43.24%	13.01%	74.85%	20.20%	51.69%	40.91%	29.64%	-18.07%	-4.74%	Upgrade
Receivables	1,563	1,442	1,137	885.4	633.52	409.69	281.34	200.36	173.84	75.96	Upgrade
Inventory	738.8	460.6	353.1	280.8	167.5	124.36	111.83	77.6	57.21	30.85	Upgrade
Other Current Assets	623.7	553.5	545.8	308.3	213.52	140.82	167.12	71.25	32.65	44	Upgrade
Total Current Assets	14,144	13,235	9,561	8,133	4,823	3,843	2,649	1,832	1,407	1,547	Upgrade
Property, Plant & Equipment	1,453	1,456	1,424	1,284	833.28	812.01	789.44	698.36	697.72	715.81	Upgrade
Long-Term Investments	2,498	112.2	0	0	0	0	0	20.28	30	0	Upgrade
Goodwill and Intangibles	1,928	1,692	1,402	1,402	1,402	50.38	79.38	334.72	334.72	68.92	Upgrade
Other Long-Term Assets	2,707	1,657	1,045	932.1	1,260	1,540	28.23	11.89	29	3.44	Upgrade
Total Long-Term Assets	8,586	4,916	3,872	3,618	3,496	2,403	897.05	1,065	1,091	788.17	Upgrade
Total Assets	22,730	18,151	13,433	11,752	8,318	6,246	3,546	2,897	2,499	2,335	Upgrade
Accounts Payable	364.9	303.9	195	155.1	87.61	110.99	73.99	61.45	74.94	71.19	Upgrade
Deferred Revenue	0	0	0	0	0	0	78.43	86.06	26.01	45.28	Upgrade
Current Debt	0	0	0	0	0	0	22.53	319.43	86.84	32.01	Upgrade
Other Current Liabilities	3,183	2,438	1,947	1,722	1,247	1,009	632.3	325.6	318.37	219.77	Upgrade
Total Current Liabilities	3,547	2,742	2,142	1,878	1,335	1,120	807.26	792.54	506.17	368.25	Upgrade
Long-Term Debt	724.7	810.3	887.2	889.5	622.87	581.55	583.9	521.34	739.4	792.94	Upgrade
Other Long-Term Liabilities	877.7	685.8	303.3	298	275.53	108.85	112.55	244.72	159.4	77.31	Upgrade
Total Long-Term Liabilities	1,602	1,496	1,191	1,188	898.39	690.4	696.45	766.06	898.79	870.24	Upgrade
Total Liabilities	5,150	4,238	3,333	3,065	2,233	1,811	1,504	1,559	1,405	1,238	Upgrade
Total Debt	724.7	810.3	887.2	889.5	622.87	581.55	606.43	840.76	826.24	824.95	Upgrade
Debt Growth	-10.56%	-8.67%	-0.26%	42.81%	7.10%	-4.10%	-27.87%	1.76%	0.16%	62.85%	Upgrade
Retained Earnings	10,142	6,523	3,201	858.7	-1,852.98	-2,989.48	-5,119.72	-5,373.84	-5,261.78	-4,705.45	Upgrade
Comprehensive Income	-14.3	0.8	15.9	-68.5	-1.97	0.66	-11.57	21.17	1.82	0.92	Upgrade
Shareholders' Equity	17,580	13,913	10,100	8,687	6,085	4,435	2,029	1,157	939.97	1,075	Upgrade
Net Cash / Debt	10,494	9,968	6,638	5,769	3,185	2,587	1,482	641.56	317.22	570.75	Upgrade
Net Cash / Debt Growth	5.27%	50.18%	15.05%	81.12%	23.15%	74.51%	131.04%	102.25%	-44.42%	-40.45%	Upgrade
Net Cash Per Share	40.28	38.47	25.54	21.90	12.22	9.98	5.85	2.62	1.31	2.43	Upgrade
Working Capital	10,597	10,493	7,419	6,256	3,488	2,723	1,842	1,039	900.99	1,178	Upgrade
Book Value Per Share	68.22	54.33	39.19	33.44	23.71	17.44	8.15	4.73	3.90	4.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).